Related references
Note: Only part of the references are listed.Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer
B. Weixler et al.
CELLULAR ONCOLOGY (2017)
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Colon Cancer
Jon D. Vogel et al.
DISEASES OF THE COLON & RECTUM (2017)
A meta-analysis of CXCL12 expression for cancer prognosis
Harsh Samarendra et al.
BRITISH JOURNAL OF CANCER (2017)
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
F. Guo et al.
ONCOGENE (2016)
CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer
Luka Stanisavljevic et al.
TUMOR BIOLOGY (2016)
MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity
Raoul A. Droeser et al.
BMC CANCER (2016)
Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung
William Sterlacci et al.
VIRCHOWS ARCHIV (2016)
Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis
Sameh Amara et al.
CANCER BIOMARKERS (2015)
Stromal CD8+ T-cell Density-A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer
Tom Donnem et al.
CLINICAL CANCER RESEARCH (2015)
Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis
Silvio Daester et al.
ONCOIMMUNOLOGY (2015)
High Frequency of CD8 Positive Lymphocyte Infiltration Correlates with Lack of Lymph Node Involvement in Early Rectal Cancer
Silvio Daester et al.
DISEASE MARKERS (2014)
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jerome Galon et al.
JOURNAL OF PATHOLOGY (2014)
CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis
Ishan Roy et al.
PLOS ONE (2014)
High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic Factor
Raoul A. Droeser et al.
PLOS ONE (2013)
CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer
Nozomu Sakai et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
TNM Staging in Colorectal Cancer: T Is for T Cell and M Is for Memory
Elizabeth K. Broussard et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
Bernhard Mlecnik et al.
GASTROENTEROLOGY (2010)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer
Inti Zlobec et al.
PLOS ONE (2010)
Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma
Yuri Akishima-Fukasawa et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival
Valentina Mirisola et al.
EUROPEAN JOURNAL OF CANCER (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clinical implication of CXCL12 expression in gastric cancer
Sumiya Ishigami et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer
Inti Zlobec et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
The future of the TNM staging system in colorectal cancer: time for a debate?
Philip Quirke et al.
LANCET ONCOLOGY (2007)
Prognostic role of CD8+tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability
F Prall et al.
HUMAN PATHOLOGY (2004)
Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma
S Kondratiev et al.
CLINICAL CANCER RESEARCH (2004)
Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma:: possible association with suppression of micrometastasis
T Chiba et al.
BRITISH JOURNAL OF CANCER (2004)
Survival Analysis Part II: Multivariate data analysis - an introduction to concepts and methods
MJ Bradburn et al.
BRITISH JOURNAL OF CANCER (2003)
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases
RJ Phillips et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Tissue microarrays in drug discovery
G Sauter et al.
NATURE REVIEWS DRUG DISCOVERY (2003)